1. Giovanna L. Gallo, Valko A, Herrera Aguilar N, Weisz A, D'Alessio C. A novel fission yeast platform
to model N -glycosylation and the bases of congenital disorders of glycosylation Type I. J Cell Sci (2022)
135 (5): jcs259167. https://doi.org/10.1242/jcs.259167.

2. Deconstructing virus condensation. Lopez N, Camporeale G, Salgueiro M, Borkosky SS, Visentín
A, Peralta-Martinez R, Loureiro ME, de Prat-Gay G. PLoS Pathog. 2021 Oct 14;17(10):e1009926. doi:
10.1371/journal.ppat.1009926. PMID: 34648608; PMCID: PMC8516229.

3. Marrero Diaz de Villegas R, Seki C, Mattion NM, König GA. Functional and in silico
Characterization of Neutralizing Interactions Between Antibodies and the Foot-and-Mouth Disease Virus
Immunodominant Antigenic Site. Front Vet Sci. 2021 May 7;8:554383. doi: 10.3389/fvets.2021.554383.
PMID: 34026880; PMCID: PMC8137985.

4. Giraudy I, Ovejero CA, Affranchino JL, González SA. In vitro inhibitory effect of maraviroc on the
association of the simian immunodeficiency virus envelope glycoprotein with CCR5. Virus Genes. 2021
Feb;57(1):106-110. doi: 10.1007/s11262-020-01816-7. Epub 2021 Jan 5. PMID: 33400102.

5. Romanutti C, Keller L, Zanetti FA. Current status of virus-vectored vaccines against pathogens
that affect poultry. Vaccine. 2020 Oct 21;38(45):6990-7001. doi: 10.1016/j.vaccine.2020.09.013. Epub
2020 Sep 18. PMID: 32951939.

6. Bergmann IE, Malirat V, Pedemonte A, Maradei E. Challenges in foot-and-mouth disease virus
strain selection as an input to attain broad vaccine intraserotype cross-protection. Expert Rev Vaccines.
2021 Jan;20(1):13-22. doi: 10.1080/14760584.2021.1877137. Epub 2021 Feb 1. PMID: 33455492.

7. Foscaldi, S.; Loureiro, M.E.; Sepúlveda, C.; Palacios, C.; Forlenza, M.B.; López, N. Development of
a Reverse Genetic System to Generate Recombinant Chimeric Tacaribe Virus That Expresses Junín Virus
Glycoproteins. Pathogens 2020, 9, 948. https://doi.org/10.3390/pathogens9110948.

8. Ziraldo Micaela, Bidart Juan E., Prato Cecilia A., Tribulatti María V., Zamorano Patricia, Mattion
Nora, D’Antuono Alejandra L. Optimized Adenoviral Vector That Enhances the Assembly of FMDV O1
Virus-Like Particles in situ Increases Its Potential as Vaccine for Serotype O Viruses Frontiers in
Microbiology 2020, 11, 2591. https://www.frontiersin.org/article/10.3389/fmicb.2020.591019
DOI=10.3389/fmicb.2020.591019.

9. Romanutti C, Keller L, La Torre J, Panzera Y, Fuques E, Pérez R, Gallo Calderon M. Virus isolation
and full-length genome sequencing of a representative canine distemper virus wild type strain of the
South America 2 clade. J Virol Methods. 2020 May; 279:113857. doi: 10.1016/j.jviromet.2020.113857.

10. María Eugenia Loureiro, Alejandra D’Antuono and Nora López. Virus–Host Interactions Involved
in Lassa Virus Entry and Genome Replication”. Pathogens 2019, 8, 17; doi:10.3390/pathogens8010017.

11. Ribeiro MS, Ayllón T, Malirat V, Cardoso Portela Câmara D, Giordano Dias CM, Louzada G,
Fernandes-Ferreira D, de Andrade Medronho R and Campos Acevedo R. High Prevalence of a Newly
Discovered Wutai Mosquito Phasivirus in Mosquitoes from Rio de Janeiro, Brazil. Insects 10, 2019, 135;
doi:10.3390/insects10050135.

12. María Eugenia Loureiro, Andre Luiz Zorzetto-Fernandes, Sheli Radoshitzky, Xiaoli Chi, Simone
Dallari, Nuha Marooki, Psylvia Lèger, Sabrina Foscaldi, Vince Harjono, Sonia Sharma, Brian M. Zid, Nora
López, Juan Carlos de la Torre, Sina Bavari and Elina Zúñiga. DDX3 suppresses type I interferons and
favors viral replication during Arenavirus infection. Plos Pathogens, July 12, 2018.
https://doi.org/10.1371/journal.ppat.1007125.

13. Galdo Novo S, Malirat V, Maradei ED, Pedemonte AR, Espinoza AM, Smitsaart E, Lee, KN; Park
JH; Bergmann IE (Corresponding). Efficacy of a high quality O1/Campos foot-and-mouth disease vaccine
upon challenge with a heterologous Korean O Mya98 lineage virus in pigs. Vaccine 36, 2018, 1570-1576.
2.

14. Jesús E. Brunetti, Sabrina Foscaldi, Verónica M. Quintana, Luis A. Scolaro, Nora López, Viviana
Castilla. Role of ERK1/2 signaling pathway in the replication of Junín and Tacaribe viruses. Viruses 2018,
10(4), 199; doi:10.3390/v10040199.

15. Grecco, S; Iraola, G.; De Caro, N; Alfieri, A.; Gallo Calderon M, Silva AP et al. Inter and intra
continental migrations and local differentiation have shaped the contemporary epidemiological
landscape of canine parvovirus in South America. Virus Evolution 2018, Vol 4 (1). Doi 10.1093/vey011.

16. Sabrina Foscaldi, Alejandra D’Antuono, María Gabriela Noval, Gonzalo de Prat Gay, Luis Scolaro,
and Nora López. Regulation of Tacaribe Mammarenavirus Translation: Positive 5’ and Negative 3’
Elements, and Role of Key Cellular Factors.” Journal of Virology 2017, posted online 3 May 2017
doi:10.1128/JVI.00084-17.

17. Ibañez LI, Caldevilla CA, Paredes Rojas Y, Mattion N. Genetic and subunit vaccines based on the
stem domain of the Equine influenza hemagglutinin provide homotypic protection against heterologous
strains. Julio 2017. Vaccine, Elsevier.

18. Lotufo C, Wilda M, Giraldez A, Grigera P, Mattion N. Impact of mutated amino acids in the N-
terminal and major hydrophobic domains of 3A protein in a Foot-and-mouth Disease Virus replicon
system. Julio 2017. Virology, Elsevier.

19. Lotufo C, Bergmann I, Mattion N, Wilda M, Grigera P. Recombinant Foot-and-Mouth Disease
(FMDV) nonstructural protein 3A fused to green fluorescent protein (GFP) as a candidate probe to
identify FMDV infected cattle in serosurveys. Archives of Virology, 2017 Aug;162(8):2279-2286. doi:
10.1007/s00705-017-3359-4. Epub 2017 Apr 18.

20. Amorim R, de Meneses MDF, Borges JC, da Silva Pinheiro LC, Caldas LA, Cirne-Santos CC, de Mello
MVP, de Souza AMT, Castro HC, de Palmer Paixão ICN, Campos RM, Bergmann IE, Malirat V, Bernardino
AMR, Rebello MA, Ferreira DF. Thieno[2,3-b]pyridine derivatives: a new class of antiviral drugs against
Mayaro virus. Arch Virol. 162(6), 2017, 1577-1587.

21. Galdo Novo S, Malirat V. Maradei E, Espinoza A, Smitsaart E, Pedemonte A, Mattion N,
Bergmann I. Antigenic and immunogenic spectrum of Foot-and-Mouth Disease vaccine strain O1
Campos against representative viruses of topotypes that circulated in Asia over the past decade.
Vaccine, 2017, 35:2303-2307.

22. Bronsvoort BM, Handel IG, Nfon CK, Sørensen KJ, Malirat V, Bergmann I, Tanya VN, Morgan KL.
Redefining the "carrier" state for foot-and-mouth disease from the dynamics of virus persistence in
endemically affected cattle populations. Sci Rep. 6, 2016, 29059.

23. Romanutti C., Gallo Calderón M., Keller L., Mattion N., La Torre J. RT-PCR and sequence analysis of
the full-length Fusion protein of Canine Distemper Virus from domestic dogs. J. Virol Methods 2016,
228:79-83.

24. Smitsaart, E. & Bergmann, I.E. “Quality attributes of current inactivated foot-and-mouth disease
vaccines and their effects on the success of vaccination programmes”. Foot and Mouth Disease Virus:
Current Research and Emerging Trends. Chapter 12 p 287-316. Eds Horizon Scientific Press-Caister
Academic Press, 2016.

25. Gallo Calderón M, Romanutti C, Wilda M, D’ Antuono A, Keller L, Giacomodonato M, Mattion N,
La Torre J. Resurgence of canine parvovirus 2a strain in the domestic dog population from Argentina. J
Virol Methods 2015, 222, 145-149.

26. Smitsaart, E.; Espinoza, A.M.; Maradei, E.; Cosentino, B.; Guinzburg, M.; Madonni, G.; Cadenazzi, G.;
Bottini, R.; Filippi, G. & Bergmann, I.E. “Importance of foot and mouth disease vaccine purity in interpreting
serological surveys”. Rev. sci. tech. Off. Int. Epiz (OIE) 34 (3), 2015, 741-66.

27. Hernández M., Tomás G, Marandino A., Iraola G., Maya L., Mattion N., Hernández D., Villegas P.,
Banda A., Panzera Y, Pérez R. Genetic characterization of South American Infectious Bursal Disease Virus

reveals the existence of a distinct worldwide-spread genetic lineage". Avian Pathology
2015, 44 (3), pp. 212-221.

28. Palacios, C., J. Claus and N. Mattion. Rotavirus VP6 protein expressed in cell culture by HSV-1-
based vectors. Rev. Arg. Microbiol. 2015, 47(1), 80-81.

29. Rosana Mattiello, Elisa D’Ambrosio, Maximiliano Wilda, Melisa Sayé, Mariana R. Miranda, Pablo
Maure, Claudio A. Pereira and Fabio A. Digirolamo. A Preventive Cytokine Treatment of the Viral
Infectious Bursal Disease (IBD) of Chickens. J. Poult. Sci., 52: 145-150, 2015.